Prospective Study of Benznidazole for Chagas' Disease Children With

See also
Status	Clinical Trial	Phase
Completed	`NCT01162967` - Clinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And Benznidazole	Phase 2
Completed	`NCT00023556` - Genetic Architecture of Heart Disease in Rural Brazil	N/A
Recruiting	`NCT05868005` - Delivering a Multi-disease Screening Tool to Migrant Populations	N/A
Completed	`NCT03892213` - Pharmacokinetic Drug-Drug Interaction Study	Phase 1
Recruiting	`NCT00875173` - Selenium Treatment and Chagasic Cardiopathy (STCC)	Phase 3
Recruiting	`NCT03704181` - Colchicine for Patients With Chagas´ Disease( B1 Stage)	Phase 2
Active, not recruiting	`NCT03378661` - BENDITA BEnznidazole New Doses Improved Treatment and Associations	Phase 2
Completed	`NCT01927224` - Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas' Patients	Phase 1
Completed	`NCT01006486` - Outcomes of an Anticoagulation Clinic in an University Hospital	Phase 4
Completed	`NCT00123916` - BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease	Phase 3
Completed	`NCT02516293` - Cardiac Rehabilitation in Chagas Heart Failure	Phase 2/Phase 3
Completed	`NCT02517632` - Physical Exercise Program in Chronic Chagas Heart Disease	Phase 3
Recruiting	`NCT02099903` - Renal Denervation in Patients With Heart Failure Secondary to Chagas Disease	N/A
Completed	`NCT01874795` - Effect of Ganglionar Electrical Stimulation on Central Arterial Pressure	N/A
Completed	`NCT01006473` - Exercise Training in Chagas Cardiomyopathy	Phase 4
Completed	`NCT02386358` - Etiologic Treatment With Benznidazole in Adult Patients With Chronic Chagas Disease. A Randomized Clinical Trial	Phase 3
Not yet recruiting	`NCT05477953` - An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About the Risk of Pregnancy Complications and About the Mother's and Baby's Health
Completed	`NCT02346123` - Determination of Genetic Polymorphisms in Chronic Chagas Cardiomyopathy	N/A
Recruiting	`NCT02295215` - Exercise Training in Patients With Chagasic Heart Disease Without Ventricular Dysfunction	N/A
Completed	`NCT03350295` - Study Will Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg Tablets Exhibiting Different in Vitro Dissolution Characteristics, and to Evaluate the Relative Bioavailability of Nifurtimox 30 mg and 120 mg	Phase 1

NCT number	NCT04024163
Study type	Interventional
Source	Insud Pharma
Contact
Status	Active, not recruiting
Phase	Phase 3
Start date	September 19, 2019
Completion date	March 30, 2028

Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms